The U.S. Food and Drug Administration on Wednesday approved a second oral GLP-1 medication, giving adults eligible for weight loss medication another option. The new pill, called Foundayo, is made by ...

The US Food and Drug Administration on Wednesday approved the second GLP-1 pill for weight loss, adding another option to a rapidly growing arsenal of obesity therapies.

Add Yahoo as a preferred source to see more of our stories on Google. At the end of a seemingly ubiquitous commercial for telehealth company Ro, a characteristically flabbergasted Charles Barkley ...

A common side effect of many GLP-1 drugs is hair loss. It's creating a formerly untapped but growing market for hair treatment products.

A doctor discusses common issues and questions around Foundayo, the oral obesity pill approved by the FDA this week.

Demand for weight loss drugs is ballooning across the U.S. — and Amazon wants in. The Seattle-based tech giant launched its ...

By Christy Santhosh May 1 (Reuters) - Eli Lilly's newly launched oral weight-loss drug, Foundayo, was prescribed 5,612 times ...

The drug offers simple dosing with just one or two capsules a day taken approximately an hour before travel. ・Patients can access Nereus at a cash-pay price of just $85 per dose, a meaningful discount ...

SINCE 2000. THERE’S A NEW REPORT THAT’S OUT TONIGHT THAT FINDS THAT WOMEN ARE LOSING MORE WEIGHT WITH GLP ONES THAN MEN. SO HERE TO ANSWER THAT, JUST TO TALK ABOUT IT, DOCTOR TODD ELLEN FROM SOUTH ...